SAFIRE: AI predicted ADME for drug discovery: leveraging BioPrint
Join Dr Carleton Sage to learn about predicting ADME properties as a key approach to improving the efficiency of small molecule drug discovery. AI ADME model development approaches and case studies within drug discovery projects will be discussed.
Women in STEM with Avideh Nazeri
By Avideh Nazeri (Novo Nordisk)
Targeting CD40 with bispecifics to outsmart tumours
By Søren Bregenholt (Alligator Biosciences)
Leveraging agonist antibodies to address immunological diseases
By Dr Judy Chou (AltruBio Inc)
The essential role of recombinant phage display antibody libraries
By John Cardone (Bio-Rad Laboratories)
Beyond the lab: neuroscience
Download this free report to explore the future of neuroscience and current developments in drug discovery. It features interviews with experts discussing challenges and historical influences in the field, the role of neuroscientists in addressing environmental issues, and personal journeys in neuroscience.